Horizon Pharma Buying Hyperion For About $1.1 Billion

NEW YORK (AP) — Horizon Pharma is buying Hyperion Therapeutics for about $1.1 billion, gaining two treatments for genetic disorders.

BING NEWS:
  • Hepion Pharma Shares Plunge 31% After Disclosing Plans to Wind Down Trial
    By Stephen Nakrosis Shares of Hepion Pharmaceuticals dropped in post-market on Friday after it disclosed plans to wind down its Ascend-Nash trial, which ...
    04/19/2024 - 11:29 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News